Matuschek, C.; Jazmati, D.; Bölke, E.; Tamaskovics, B.; Corradini, S.; Budach, W.; Krug, D.; Mohrmann, S.; Ruckhäberle, E.; Fehm, T.;
et al. Post-Neoadjuvant Treatment Strategies in Breast Cancer. Cancers 2022, 14, 1246.
https://doi.org/10.3390/cancers14051246
AMA Style
Matuschek C, Jazmati D, Bölke E, Tamaskovics B, Corradini S, Budach W, Krug D, Mohrmann S, Ruckhäberle E, Fehm T,
et al. Post-Neoadjuvant Treatment Strategies in Breast Cancer. Cancers. 2022; 14(5):1246.
https://doi.org/10.3390/cancers14051246
Chicago/Turabian Style
Matuschek, Christiane, Danny Jazmati, Edwin Bölke, Bálint Tamaskovics, Stefanie Corradini, Wilfried Budach, David Krug, Svjetlana Mohrmann, Eugen Ruckhäberle, Tanja Fehm,
and et al. 2022. "Post-Neoadjuvant Treatment Strategies in Breast Cancer" Cancers 14, no. 5: 1246.
https://doi.org/10.3390/cancers14051246
APA Style
Matuschek, C., Jazmati, D., Bölke, E., Tamaskovics, B., Corradini, S., Budach, W., Krug, D., Mohrmann, S., Ruckhäberle, E., Fehm, T., Nestle Krämling, C., Dommach, M., & Haussmann, J.
(2022). Post-Neoadjuvant Treatment Strategies in Breast Cancer. Cancers, 14(5), 1246.
https://doi.org/10.3390/cancers14051246
